BLFS

BioLife Solutions, Inc

BLFS · CIK 834365 · Annual (10-K) · Last 8 years

Financial Trends

Revenue
20182025
Net Income−$5M
20182025
Operating CF$20M
20182025
Free Cash Flow$11M
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue————————
Cost of Revenue$0.0B—————$0.0B$0.0B
Gross Profit$0.1B——————$0.0B
R&D Expense$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
SG&A Expense————————
Operating Income$-0.0B$-0.0B$-0.1B$-0.1B$-0.0B$-0.0B$-0.0B$0.0B
Net Income$-0.0B$-0.0B$-0.1B$-0.1B$-0.0B$0.0B$-0.0B$0.0B
EPS (Basic)$-0.09$-0.44$-1.52$-3.29$-0.20$0.09$0.42$0.18
EPS (Diluted)$-0.10$-0.44$-1.52$-3.29$-0.20$-0.03$0.35$0.14

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$0.4B$0.4B$0.4B$0.5B$0.6B$0.2B$0.1B$0.0B
Current Assets$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B$0.0B$0.0B
Cash & Equivalents$0.0B$0.1B$0.0B$0.0B$0.1B$0.1B$0.0B$0.0B
Total Liabilities$0.0B$0.1B$0.1B$0.1B$0.1B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.4B$0.3B$0.3B$0.4B$0.5B$0.2B$0.0B$0.0B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$0.0B$0.0B$-0.0B$-0.0B$-0.0B$0.0B$0.0B$0.0B
Investing Cash Flow$-0.1B$0.1B$0.0B$-0.1B$-0.0B$-0.0B$-0.0B$-0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$-0.0B$-0.0B$0.0B$0.0B$-0.0B$0.1B$0.0B$0.0B
← Companies